Liu Y - Search Results

1

[Multi-institutional randomized controlled clinical trial on China made 4-demethoxydaunokrubicin (IDA) in the treatment of acute leukemia].

Liu Y, Ke XY, Ma J, Shen ZX, Zhang XH, Du X, Zhao YM, Lü JQ, Zhan ZM, Zeng XY, Xu XH, Lu ZS. Liu Y, et al. Zhonghua Zhong Liu Za Zhi. 2005 Dec;27(12):750-2. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16483490 Clinical Trial. Chinese.

2

[Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].

Liu Y, Ke XY, Ma J, Shen ZX, Zhang XH, Du X, Zhao YM, Lv JQ, Zhan ZM, Zeng XY, Xu XH, Lu ZS. Liu Y, et al. Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):706-8. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17274381 Clinical Trial. Chinese.

3

Intraoperative monitoring for safety of total hip arthroplasty using third-generation cementing technique.

Li ZJ, Zhang K, Yang H, Liu Y, Lü JQ. Li ZJ, et al. Among authors: liu y. Chin Med J (Engl). 2009 Jan 20;122(2):174-7. Chin Med J (Engl). 2009. PMID: 19187642

4

[Clinical Characteristics and Prognosis of Acute Myeloid Leukemia with FLT3-ITD Mutation].

Liu Y, Ke XY, Wang J, Wang JJ, Jing HM, Dong F. Liu Y, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Apr;26(2):354-358. doi: 10.7534/j.issn.1009-2137.2018.02.008. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018. PMID: 29665898 Chinese.

5

[Analysis of clinical characteristics and prognostic factors of 110 cases with primary gastrointestinal tract non-Hodgkin's lymphoma].

Wan W, Wang J, Jing HM, Wang JJ, Liu Y, Zhao W, Chen YP, Ke XY. Wan W, et al. Among authors: liu y. Zhonghua Xue Ye Xue Za Zhi. 2011 Oct;32(10):652-5. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 22339820 Chinese.

6

[Clinical characteristics and prognostic factors of 62 cases with Hodgkin lymphoma].

Wan WL, Tian L, Wang J, Zhang W, Jing HM, Wang JJ, Liu Y, Hou SL, Ke XY. Wan WL, et al. Among authors: liu y. Zhonghua Xue Ye Xue Za Zhi. 2013 Jul;34(7):618-21. doi: 10.3760/cma.j.issn.0253-2727.2013.07.013. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23906458 Chinese.

7

[Clinical characteristics of multiple myeloma with renal impairment and the efficacy of different treatments].

Liu Y, Ke X, Wang J, Wang Y, Wan W, Zhang W. Liu Y, et al. Zhonghua Xue Ye Xue Za Zhi. 2014 Sep;35(9):842-4. doi: 10.3760/cma.j.issn.0253-2727.2014.09.013. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 25246256 Chinese. No abstract available.

8

[Clinical characteristics and therapeutic efficacy of immunoglobin D multiple myeloma].

Liu Y, Ke XY, Wang J, Jing HM, Wang JJ, Dong F, Wan WL, Zhang W. Liu Y, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Dec;22(6):1628-32. doi: 10.7534/j.issn.1009-2137.2014.06.024. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014. PMID: 25543487 Chinese.

9

[Clinical Features and Response to Treatment in Newly Diagnosed Multiple Myeloma Patients with Deletion 17P].

Liu Y, Ke XY, Wang J, Wang YF, Dong F, Tian L, Wan W, Jing HM. Liu Y, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Jun;25(3):802-806. doi: 10.7534/j.issn.1009-2137.2017.03.030. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017. PMID: 28641639 Chinese.

10

[Relationship between Bone Markers and the Progression of Multiple Myeloma].

Liu Y, Ke XY, Tian L, Wan W, Dong F, Wang J. Liu Y, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Oct;24(5):1433-1436. doi: 10.7534/j.issn.1009-2137.2016.05.027. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016. PMID: 27784370 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205,672 results

Search Page

Filters